Search

Kristin Ann Vajda

Examiner (ID: 10363, Phone: (571)270-5232 , Office: P/1626 )

Most Active Art Unit
1622
Art Unit(s)
4131, 1622, 1626
Total Applications
2296
Issued Applications
1831
Pending Applications
129
Abandoned Applications
372

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19543060 [patent_doc_number] => 20240360096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => CANNABINOIDS FROM SUBSTITUTED RESORCINOL CARBOXYLIC ACIDS [patent_app_type] => utility [patent_app_number] => 18/553525 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4617 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553525 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/553525
CANNABINOIDS FROM SUBSTITUTED RESORCINOL CARBOXYLIC ACIDS Mar 31, 2022 Abandoned
Array ( [id] => 20645811 [patent_doc_number] => 12600745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-04-14 [patent_title] => Process for preparing B-[(7a, 1713)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid [patent_app_type] => utility [patent_app_number] => 18/281943 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18281943 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/281943
Process for preparing B-[(7a, 1713)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid Mar 28, 2022 Issued
Array ( [id] => 17895289 [patent_doc_number] => 20220304951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => ANTICANCER COMPOSITIONS AND METHODS FOR USING SAME [patent_app_type] => utility [patent_app_number] => 17/706565 [patent_app_country] => US [patent_app_date] => 2022-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19988 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17706565 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/706565
ANTICANCER COMPOSITIONS AND METHODS FOR USING SAME Mar 27, 2022 Abandoned
Array ( [id] => 20687666 [patent_doc_number] => 12617801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-05 [patent_title] => Tetrahydrothieno pyridine derivatives as DDRS inhibitors [patent_app_type] => utility [patent_app_number] => 18/283867 [patent_app_country] => US [patent_app_date] => 2022-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22506 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283867 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/283867
Tetrahydrothieno pyridine derivatives as DDRS inhibitors Mar 24, 2022 Issued
Array ( [id] => 18518482 [patent_doc_number] => 11708362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-25 [patent_title] => Process for preparing aminopyrimidine derivatives [patent_app_type] => utility [patent_app_number] => 17/704718 [patent_app_country] => US [patent_app_date] => 2022-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7333 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17704718 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/704718
Process for preparing aminopyrimidine derivatives Mar 24, 2022 Issued
Array ( [id] => 17982528 [patent_doc_number] => 20220348564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/702835 [patent_app_country] => US [patent_app_date] => 2022-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47969 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702835 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/702835
PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-PHENYL-, PHENYL-[1,3]DIOXOLO[4,5-C]PYRIDINYL-HETEROARYL-, OR PHENYL-(1,3)DIOXO[4,5-C]PYRIDINYL-PIPERIDINYL-METHYL-OXETANYLMETHYL-1H-BENZO[D]IMIDAZOLE-CARBOXYLIC ACID DERIVATIVES AND METHODS OF USING SAME Mar 23, 2022 Abandoned
Array ( [id] => 19201374 [patent_doc_number] => 20240173273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => USE OF PANTETHINE FOR THE TREATMENT OF SARS COV-2 INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/282677 [patent_app_country] => US [patent_app_date] => 2022-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282677 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/282677
USE OF PANTETHINE FOR THE TREATMENT OF SARS COV-2 INFECTIONS Mar 22, 2022 Pending
Array ( [id] => 18211329 [patent_doc_number] => 20230057592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION [patent_app_type] => utility [patent_app_number] => 17/697893 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697893 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697893
USE OF H3K9me3 MODULATION FOR ENHANCING COGNITIVE FUNCTION Mar 16, 2022 Abandoned
Array ( [id] => 19777360 [patent_doc_number] => 12226380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Method of regulating immunity in the intestines [patent_app_type] => utility [patent_app_number] => 17/697089 [patent_app_country] => US [patent_app_date] => 2022-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4183 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697089 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/697089
Method of regulating immunity in the intestines Mar 16, 2022 Issued
Array ( [id] => 19233661 [patent_doc_number] => 20240190853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => FLUORINATED PYRIMIDINE COMPOUND AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 18/282718 [patent_app_country] => US [patent_app_date] => 2022-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 172 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282718 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/282718
Fluorinated pyrimidine compound and method for producing same Mar 15, 2022 Issued
Array ( [id] => 18700015 [patent_doc_number] => 11786501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => Nitroxyl donors with improved therapeutic index [patent_app_type] => utility [patent_app_number] => 17/694500 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21129 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694500 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/694500
Nitroxyl donors with improved therapeutic index Mar 13, 2022 Issued
Array ( [id] => 17850495 [patent_doc_number] => 20220280536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/653587 [patent_app_country] => US [patent_app_date] => 2022-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14568 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653587 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653587
Pharmaceutical composition Mar 3, 2022 Issued
Array ( [id] => 17945721 [patent_doc_number] => 20220332738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => PREPARATION METHOD OF A CYCLIC PHOSPHONATE COMPOUND [patent_app_type] => utility [patent_app_number] => 17/653396 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653396 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653396
Preparation method of a cyclic phosphonate compound Mar 2, 2022 Issued
Array ( [id] => 18147627 [patent_doc_number] => 20230021484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-26 [patent_title] => Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels [patent_app_type] => utility [patent_app_number] => 17/685944 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35645 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17685944 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/685944
Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels Mar 2, 2022 Abandoned
Array ( [id] => 18252360 [patent_doc_number] => 20230079399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/682654 [patent_app_country] => US [patent_app_date] => 2022-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44552 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17682654 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/682654
Substituted quinoline analogs as aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors Feb 27, 2022 Issued
Array ( [id] => 17657033 [patent_doc_number] => 20220177498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => CRYSTALLINE FORM OF L-GLUFOSINATE AMMONIUM SALT AND PROCESS FOR PRODUCTION THEREOF [patent_app_type] => utility [patent_app_number] => 17/678283 [patent_app_country] => US [patent_app_date] => 2022-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17678283 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/678283
Crystalline form of L-glufosinate ammonium salt and process for production thereof Feb 22, 2022 Issued
Array ( [id] => 19187699 [patent_doc_number] => 20240166612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/275880 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -67 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18275880 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/275880
ARYLTHIOETHER ACETAMIDE AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS Feb 17, 2022 Pending
Array ( [id] => 18764019 [patent_doc_number] => 11814405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-14 [patent_title] => Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereof [patent_app_type] => utility [patent_app_number] => 17/675681 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4348 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675681 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675681
Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereof Feb 17, 2022 Issued
Array ( [id] => 19186161 [patent_doc_number] => 20240165074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA [patent_app_type] => utility [patent_app_number] => 18/549124 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18549124 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/549124
COMPOSITION OF THE PHYTOCOMPOUNDS INTENDED TO ENHANCE CYTOTOXIC ACTIVITY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA Feb 9, 2022 Pending
Array ( [id] => 18558755 [patent_doc_number] => 11723980 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => IRAK degraders and uses thereof [patent_app_type] => utility [patent_app_number] => 17/650545 [patent_app_country] => US [patent_app_date] => 2022-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 381790 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 840 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17650545 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/650545
IRAK degraders and uses thereof Feb 9, 2022 Issued
Menu